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D. Venkata Rao, M.D. and Richard Johnson, M.D.* 
Washington University School of Medicine, Roswell Park Memorial Institute* 
and the Radiation Therapy Oncology Group 
Summary 
This report summarizes the preliminary experience on 26 patients treated at the 
Mallinckrodt Institute of Radiology with hyperthermia and irradiation. Patients were 
treated with 400 rad fractions given every 72 hours (twice weekly) for a total of 2400, 
2800, 3200 or 4000 rad followed by hyperthermia. In addition 18 lesions were treated 
according to a protocol designed by the Radiation Therapy Oncology Group (RTOG) for 
superficial measurable tumors randomized lesions to receive three doses of 500 rad 
followed by hyperthermia (6 lesions), or irradiation alone (three doses of 600, 700 or 
800 rad every 72 hours. 
Hyperthermia was administered with 2450 MHz or 915 MHz microwave generators and 
appropriately designed surface applicators. Temperature used was 42.5°-43° C, 90 minutes, 
every 72 hours. Irradiation was delivered with varying energy electrons (12 to 16 Mev) 
as required by the size of the lesion and occasionally with Cobalt 60 in which case bolus 
was used to increase the surface dose. 
Of the six lesions treated with 1500 rad and hyperthermia only two metastatic 
melanomas showed complete regression, three tumors exhibited partial regression (one 
metastatic epidermoid carcinoma in the abdominal wall, a melanoma and a recurrent ductal 
breast carcinoma of the chest wall). The two melanoma nodules with CR remained under 
control for 12 and 16 months after therapy. A metastatic melanoma nodule showed no 
significant regression. Nine of the 12 control lesions treated with radiotherapy alone, 
mostly melanoma or recurrent carcinoma of the breast showed complete regression after 
doses of irradiation alone varying from 1800 to 2400 in three fractions. The other three 
lesions had 50% or more regression of the tumor. Some of the patients had control of the 
lesions for 12 to 16 months after therapy. I t was apparent that 1500 rad and hyperthermia 
were not as effective as higher doses of irradiation alone. 
The patients treated on the intramural protocol (doses of 2400 to 4000 rad and 
hyperthermia) had recurrent lesions from epidermoid carcinoma of the head and neck or 
adenocarcinoma of the breast, most of them previously irradiated with doses ranging from 
4000 to 6000 rad; other tumors included several metastatic melanoma nodules. 
Four of six recurrent epidermoid carcinoma of the head and neck showed complete 
regression and two others 20 and 40% regression. Of three metastatic melanoma nodules 
treated with irradiation and hyperthermia two showed complete regression of the tumors 
and over 80% regression, all lasting from five to eight months. 
Of eight recurrent adenocarcinoma of the breast nodules in the chest wall, two were 
treated with doses of 2000 rad and showed only minimal regression of the tumor and regrew 
within two months from treatment. This is contrasted with six other lesions, treated with 
eight or 10 fractions of 400 rad each; four lesions exhibiting complete regression and the 
other two about 80%, with a duration of about three months. 
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Further, three patients with rather extensive recurrent adenocarcinoma of the breast 
in the chest wall were treated with heat alone because of high doses of irradiation 
delivered previously, only minimal tumor regression was noted (less than 25%). One 
patient with recurrent laryngeal carcinoma in the neck treated with heat alone exhibited 
complete tumor regression, s t i l l present, 18 months after hyperthermia. 
The doses of radiation and heat delivered have been extremely well tolerated by the 
normal tissues. Of the 34 sites treated, three (8%) developed blisters, three (8%) 
erythema only, three additional patients (8%) moist desquamation and 14 (41%) dry 
desquamation. There have been no instances of ulceration, necrosis or severe fibrosis 
in the treated areas, even in the patients surviving over one year. 
In view of these preliminary observations we feel that additional clinical trials are 
warranted to assess the potential value of hyperthermia alone or combined with irradiation 
in the treatment of selected cancer patients. Intensive efforts will be immediately 
required to improve existing methods for delivery and measurement of heat to lesions 
located at more than 5 cm depth. 
Introduction 
Probably the f i r s t observation that heat has an effect on malignant cells was reported 
by Bush (1), who described the disappearance of a sarcoma following high fever in a patient 
with erysipela. Despite encouraging reports by Coley (2) using bacterial toxins to induce 
fever and Westermark (3), who used localized hyperthermia followed by two publications by 
Rohdenburg, 1918 (4) and Warren in 1935 (5) hyperthermia in the treatment of malignant 
disease has had minimal clinical application (6,7,8,9). 
In the past 10 years there has been a renewed interest in this modality, with a large 
number of biological papers indicating that there may be significant advantages to the use 
of heat alone or combined with irradiation or cytotoxic drugs to enhance the killing of 
tumor cells (10,11,12). 
The clinical use of localized or whole body heat has been severely hampered by the 
lack of adequate equipment to deliver effective heat in deep seated lesions and of 
thermometry techniques that may provide reliable information regarding the distribution of 
the heat in the target tissues. However, a number of institutions throughout the world 
have begun to utilize several modalities of heating (radiofrequency, microwave or ultra-
sound) in an effort to gain information relative to the tolerance of normal tissues and 
the optimal parameters of hyperthermia alone or combined with radiation to enhance tumor 
cell k i l l without damaging normal tissues. 
The following is a report of preliminary observations accumulated at the Mallinckrodt 
Institute of Radiology in a selected group of patients with recurrent or metastatic 
superficial nodules treated over a two year period (1978-1979). 
Materials and Methods 
In 1978 and 1979 a total of 26 superficial tumors were treated at the Mallinckrodt 
Institute of Radiology with hyperthermia and irradiation. 
The doses of irradiation consisted of 400 rad fractions given every 72 hours (twice 
weekly) for a total of 2400, 2800, 3200 or 4000 rad, in a dose seeking experiment to 
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assess tolerance of normal tissues and tumor response (3 to 5 patients per dose). 
In addition 18 lesions were treated according to a protocol designed by the Radiation 
Therapy Oncology Group (RTOG) for superficial measurable tumors randomized lesions to 
receive three doses of 500 rad followed by hyperthermia (43° C, 90 minutes, every 72 hours) 
or irradiation alone (three doses of 600, 700 or 800 rad every 72 hours). 
Further, two recurrent nodules of head and neck epidermoid carcinoma and three 
extensive recurrences from carcinoma of the breast in the chest wall were treated with 
heat alone. 
The equipment and techniques of heating as well as thermometry have been previously 
described (13). Microwave generators (2450 and 915 MHz) with specially designed 
applicators were used. Thermocouples were inserted at the depth of the tumor and over the 
skin surface and the temperature at these two sites was continuously recorded on a dual 
channel chart recorder. 
Irradiation was delivered with varying energy electrons (12 to 16 Mev) as required by 
the size of the lesion and occasionally with Cobalt 60 in which case bolus was used to 
increase the surface dose. 
Resul ts 
1. RTOG protocol 77-10. 
Of the six lesions treated in this protocol with irradiation and hyperthermia, two 
metastatic melanomas showed complete regression, three tumors exhibited partial regression 
(one metastatic epidermoid carcinoma in the abdominal wall, a melanoma and a recurrent 
ductal breast carcinoma of the chest wall). The two melanoma nodules with CR remained 
under control for 12 and 16 months after therapy. A metastatic melanoma nodule showed no 
significant regression. 
Some of the lesions probably did not show clinical regression because the patients 
were in a terminal state and died within weeks from therapy. 
Nine of the 12 control lesions treated with radiotherapy alone, mostly melanoma or 
recurrent carcinoma of the breast showed complete regression after doses of irradiation 
alone varying from 1800 to 2400 in three fractions. The other three lesions had 50% or 
more regression of the tumor. Some of the patients had control of the lesions for 12 to 
16 months after therapy. 
I t was apparent from this study that 1500 rad and hyperthermia were not as effective 
as higher doses of irradiation. On this basis, an intramural protocol was initiated which 
delivered higher doses of irradiation. 
2. Intramural protocol. 
The patients treated on the Washington University intramural protocol had recurrent 
lesions from epidermoid carcinoma of the head and neck or adenocarcinoma of the breast 
most of which had been previously irradiated with doses ranging from 4000 to 6000 rad, 
other tumors included several metastatic melanoma nodules (Tables 1 and 2). 
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Four of s ix recurrent epidermoid carcinoma of the head and neck showed complete 
regression and two others 20 and 40% regression. Of three metastat ic melanoma nodules 
treated with i r r a d i a t i o n and hyperthermia two showed complete regression of the tumors 
and one 80% regression, a l l l as t ing from f i ve to eight months. 
One of the pat ients treated with heat alone showed complete regression of a 
4 X 3 X 1 cm subcutaneous nodule with super f i c ia l u lcerat ion of the l e f t neck which 
appeared fo l lowing IJ^ years a f t e r del ivery of 5700 rad TD to the neck with Cobalt 60 and 
supraglot t ic laryngectomy. The pat ient remains free of disease 15 months a f t e r therapy. 
Another pa t ien t , wi th a 7 x 3 x 5 x . 5 c m recurrent epidermoid carcinoma of the scalp was 
treated with heat alone. Most of the tumor underwent complete regression but pers is tent 
nodule at the margin was treated with 4500 rad TD in 15 f r ac t i ons , three weeks with 
super f i c ia l x-rays (120 KV, .3 mm cu HVL). He died eight months l a te r with l i v e r 
c i r r hos i s ; there was no evidence of recurrent tumor (F ig . lA, IB ) . 
Of the three metastatic melanoma nodules, treated wi th i r r a d i a t i o n and hyperthermia 
two showed complete regression of the tumors, which lasted from f i v e to 10 months. One 
of the patients had two lesions (F ig . 2A, 2B); one was treated with i r r a d i a t i o n (5000 rad) 
and hyperthermia, wi th p rac t i ca l l y complete regression, which lasted fo r e ight months. 
The pat ient died wi th widespread metastases. The second lesion was treated with i r r a d i a t i o n 
alone (as control s i t e ) ; a regression of 75% was noted, with regrowth w i th in s ix months 
of therapy (F ig . 3 ) . ^.^^^^ 3 
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Graph showing tumor regression of several metastatic 
melanoma nodules. 
Of eight recurrent adenocarcinoma of the breast lesions in the chest wall, two were 
treated with doses of 2000 rad and they showed only minimal regression of the tumor and 
regrew within two months from treatment. This is contrasted with six other lesions, 
treated with eight or 10 fractions of 400 rad each, four lesions exhibiting 100% 
regression and the other two 80% response, with a duraction of about three months. 
In the three patients with rather extensive recurrent adenocarcinoma of the breast 
and the chest wall treated with heat alone because of high doses of irradiation delivered 
previously, only minimal regression was noted (less than 25%). 
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Normal tissue reactions 
The doses of radiation and heat have been extremely well tolerated by the normal 
tissues. Of the 34 sites treated, three (8%) developed blisters, three (8%) erythema 
only, three additional patients (8%) moist desquamation and 14 (41%) dry desquamation. 
This is in contrast to the patients treated with irradiation alone, three of whom 
developed moist desquamation with doses of 2100 and 2400 rad in three fractions (5%). 
There have been no instances of ulceration, necrosis or severe fibrosis in the 
treated areas, even in the patients surviving over one year. 
The degree of fibrosis existing at the time of the irradiation and hyperthermia, due 
to previous radiotherapy has not been aggravated by the additional hyperthermia and 
irradiation treatment. 
Discussion 
In vitro and in vivo biological experiments suggest that heat may be more damaging to 
tumor than to normal cells because of a variety of reasons, which include 1) reduced blood 
supply in the tumor, 2) possible Inherent Increased sensitivity of hypoxic cells to heat 
and 3) metabolically deprived tumor cells with reduced pH. In addition, heat affects 
cells in "S" phase, which are known to be resistant to irradiation (10,11,14). 
The sensitivity of hypoxic cells to heat is complicated by the possible association 
of low oxygen tension with nutrient deficiency or reduced pH. As pointed out by Dewey 
(11) this response of the tumor may be complicated by physiological changes associated 
with lowering In blood flow and oxygen tension produced by the hyperthermia. 
Heat causes a greater degree of mitotic delay than irradiation, and this factor may 
affect the distribution of cells in the cell cycle after heat or x-rays (15,16). 
Experiments are being conducted at the present time to separate the thermal from the 
nonthermal effects produced by some of the heating modalities used, such as ultrasound 
and radiofrequency hyperthermia. 
I t Is Important to gather information concerning the effects of heat alone or combined 
with irradiation or cytotoxic agents on human tumors. Also, of equal significance are the 
observations concerning the effects of this modality on the normal tissues. Since 
qualitatively the reactions may be similar i t is critical to quantitate as much as possible 
both tumor regression and normal tissue injury. 
In regard to normal tissue response, Moritz and Henriques (17) demonstrated that skin 
In contact with hot water would suffer severe damage once a critical temperature had been 
reached. Similar observations have been noted in the tails of baby rats immersed in hot 
water. The authors calculated that an increase of only 20% in heating time or less than 
.5° C at the critical temperature would enhance the probability of tissue necrosis from 
zero to .100%. This underlines the importance of the need for accurately measuring the 
temperature and to deliver uniform temperature in the volume treated in clinical 
applications. 
The reduction In dose of irradiation combined with heat to produce the same biological 
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effect has been defined as thermal enhancement ratio (TER). I f there is greater TER in 
tumor than normal tissues the differences is defined as therapeutic gain factor (TGF). 
Unfortunately, before an optimal clinical use of heat can be accomplished there are 
a number of technological problems related to heating sources, clinical thermometry and 
definition of a variety of treatment factors which may influence the effects of this 
modality alone or combined with irradiation which will require a great deal of effort in 
development and well designed clinical t r i a l s . 
The currently existing hyperthermia modalities, microwave, radiofrequency and 
ultrasound have inherent advantages and disadvantages which have been summarized by other 
authors (18). At the present time a major obstacle to clinical application of heat is the 
inability to deliver adequate and homogeneous temperatures to deep seated tumors (3 cm 
penetration of 915 MHz and 4 cm for 433 MHz microwave). Lower frequencies (27 MHz) may 
provide better depth temperature but heat deposition is diffuse and cannot be localized 
to small volumes. 
Also, invasive thermometry must be used with each application, which represents some 
discomfort to the patient. In addition, hyperthermia with ultrasound cannot be carried 
out with deep seated tumors unless they are near a natural hollow viscera, such as the 
esophagus, bladder, rectum etc. Furthermore, only a few points of temperature can be 
measured. This is unsatisfactory, since we know that in steady state phantoms the thermal 
distribution is not homogeneous. In addition, there is a decreased temperature in the 
depth of the tissues, due to absorption and dissipation (18). Also, the intricacies of 
the relationship between microcirculation, blood flow and temperature distribution have 
just begun to be explored (19). 
Among the biologically related events that have significant impact in clinical 
application of heat are the following: 
1. Temperature and time of heat exposure. 
In vitro and in vivo experiments have demonstrated that there is a greater degree of 
cell k i l l with increasing temperatures, particularly above 42° C. The time of exposure 
to heat and the temperature are closely interrelated. According to Henriques (20) over 
43.5 C the effect of increased temperature of 1° c is equivalent to a decrease in heating 
time by a factor of two (and vice versa). 
2. Fractionation and thermal tolerance or resistance. 
Henle and Leeper (21) have demonstrated in vitro that fractionated hyperthermia may 
result in thermal tolerance, which can be represented as an increase in the Do of a 
subsequent hyperthermia survival curve which has been distinguished from the repair of 
sublethal heat damage reflected as a return of the shoulder (21,22). The time for 
development of maximal thermal tolerance and the level of this phenomenon depend upon the 
degree of damage induced by the f i r s t heat treatment (23,24). Thermal tolerance has been 
observed in most cultured mammalian cells and in all normal tissues evaluated. Thermal 
tolerant cells may be more resistant to irradiation (21,25,26), which makes this even a 
more important problem when both modalities are combined. 
As noted by Field and Bleehen (12) low heating times at moderate temperatures may 
induce thermal resistance, which could have a profound clinical affect. 
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3. Sequential administration of heat and irradiation. 
Overgaard and Overgaard (27) observed in a mouse mammary carcinoma treated with 
27 MHz microwave that the central portion of the tumor was more severely damaged than the 
periphery. This would support the use of combined irradiation and heat, hyperthermia 
being especially effective against centrally located hypoxic cells system to irradiation 
and irradiation eliminating the tumor cells in the periphery of the tumor, where heat 
would be less effective. 
Dewey et al. (10) and Sapareto (28) have shown that cells at low pH are less efficient 
in repairing sublethal heat damage which can interact with sublethal radiation damage. 
These authors have shown in cells in vitro that when heat and irradiation are administered 
together there is a greater cell k i l l than when heat is delivered more than 30 minutes 
before or after administration of the irradiation. When the two modalities are combined 
the increased cell killing follows the pattern of direct heat injury not that of 
irradiation, thus the effect of the radioresistant S phase cells is greater than on the 
more radiosensitive cells in other portions of the cell cycle (late Gl or G2 interface). 
Dewey (11) has hypothesized that i f heat is delivered three hours prior to 
irradiation, cells with a low pH will have minimal ability to repair heat damage and 
therefore may be greatly sensitized to the affects of subsequent irradiation. In vivo 
data reported by Overgaard (27) and Stewart and Denekamp (14) in animals suggests that 
when the irradiation is delivered before the heat skin behaves like cells with normal pH 
and tumor cells as those having low pH. However, when the heating preceeds irradiation 
the data for the skin parallels that of in vitro experiments, but for tumors i t is not 
reproducible. 
Several preliminary reports on the clinical application of hyperthermia have been 
published recently. 
Hornback et al. (7) reported on 70 patients with advanced malignant tumors of various 
histological types treated with microwave radiation (433 MHz) and ionizing radiation 
(doses ranging from 1100 in two weeks to 6000 rad in six weeks). Twenty-one patients 
completed the planning course of treatment and were followed for a minimum of nine months. 
Ninety percent experienced complete relief of symptoms and 80% exhibited complete tumor 
regression. Nine of the complete responders remained free of tumor from nine to 14 months 
after therapy. The combined treatment was well tolerated, without significant skin or 
subcutaneous tissue Injury. 
LeVeen et al. (29) described the results in 21 patients with different malignant 
neoplasias treated with radiofrequency (13.56 MHz). The authors describe tumor regression 
or destruction without residual tumor at autopsy, but i t Is d i f f i c u l t to ascertain from 
their publication exactly how many patients had complete or partial tumor regression and 
how many have survived for extended periods of time after therapy. 
Kim and Hahn (30) reported partial and transitory tumor regressions in 10 of 19 
patients treated with 27.2 MHz radiofrequency Inductive heating (30 minutes, 42° C). In 
contrast, the same authors observed partial or complete tumor regression in 42 of 54 
patients receiving a combination of heat Immediately before irradiation (1000 to 2000 rad). 
These authors reported enhanced skin reactions after this combined therapy only in 
patients treated to areas Including skin grafts or extensive fibrosis from previous 
surgical procedures. 
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Marmor et al. (31) reported results in 26 evaluable courses of hyperthermia in 21 
patients with superficial metastatic or recurrent malignant tumors treated with a minimum 
of 43 C for 30 minutes given three times weekly. Tumor response was analyzed after six 
treatments. Of the lesions treated three had complete response (12%) and 11 a partial 
response (42%). Squamous cell carcinoma lesions of the head and neck showed several 
regressions (one complete only). There were five patients who developed small superficial 
cutaneous burns that healed in seven to 10 days. There were four instances of extensive 
central tumor necrosis. Ten of the 26 courses of treatment resulted in significant pain 
during the ultrasound irradiation, usually subsiding after completion of the treatment. 
There was no significant correlation between the temperature in the center of the tumor 
and the injury to the normal tissues, except that four cases of central necrosis were 
observed with temperatures above 44° C. Previous irradiation of the treated area did not 
decrease the tolerance of the normal tissues to ultrasound. 
^subsequent report by Marmor and Hahn (9) describe their experience on 16 patients 
receiving 18 courses of irradiation with ultrasound for recurrent tumors after doses of 
irradiation ranging from 4400 to 11,000 rad. Eleven of the 18 courses of ultrasound 
resulted in objective tumor response (only two complete). In addition, five previously 
irradiated patients were given six courses of heat plus low dose irradiation (1200 to 
2400 rad). Three patients showed complete tumor response and two partial tumor regression, 
suggesting that the combination of heat and irradiation was more effective than ultrasound 
alone. 
Recently, Bicher et al. (32) described the preliminary results of treatment with 
microwaves (frequencies of 2450, 915 and 300 MHz) for 90 minutes. The skin was cooled 
by an air j e t . Tissue temperature was kept at 45° C when hyperthermia alone was used and 
at 42 C in combination with radiation. Patients were treated twice a week with 72 hour 
intervals between treatments. The regime consisted of four treatments of hyperthermia 
alone followed by a week of rest. Thereafter each hyperthermia treatment was preceeed 
by a 400 rad fraction or x-irradiation delivered in four combined treatments to a total of 
1600 rad. Twenty-three patients encompassing 37 treatment fields have been entered into 
the protocol. Most tumors responded to treatment, 62% of these with total disappearance; 
skin, brain, breast and spinal cord are among the treated areas. Melanomas and lymphomas 
are the most sensitive tumors, sarcomas the most resistant; adeno and squamous cell 
carcinoma intermediate. No toxicity induced by this combination has been detected, even 
in areas previously Irradiated to high doses. 
Arcangeli et al. (33) reported on a group of 15 patients with N2 and N3 multiple 
cervical lymph nodes for head and neck cancer treated with multiple daily fractionation 
radiotherapy (total doses of 4000-7000 rad) and local hyperthermia (2450 or 915 .MHz) 
Seventeen of 20 lymph nodes (85%) treated with this combination achieved complete 
regression compared with six of 13 (46%) treated with multiple fractionation irradiation 
alone and 14 of 46 (30%1 with lymph nodes treated witn conservative fractionation 
radiotherapy (historical controls). The authors did not observe enhanced normal tissue 
reactions. 
From preliminary studies i t is apparent that heat alone, or optimally combined with 
irradiation has the ability to destroy tumor cells and has potential clinical application 
in cancer management. However, an Intensive effort must be devoted to the development of 
adequate equipment that can deliver heat to deep seated tumors, located in the thorax, 
abdomen or pelvis. Even though ultrasound has definite advantages over radiofrequency of 
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microwave in terms of depth of penetration, a major obstacle faced by this modality is the 
reduction and absence of penetrability Induced by air tissue or tissue bone interfaces. 
Furthermore, dosimetric observations have documented the lack of uniformity in heat 
distribution with some modalities and applicators as well as the non-uniform distribution 
of heat in most tumors. Stringent quality control programs in hyperthermia, like the 
irradiation must be designed to enhance the accuracy of determination of heat absorption 
in tissues and to monitor the temperature at various sites throughout the administration 
of hyperthermia. The Radiation Therapy Oncology Group is developing a collaborative 
hyperthermia physics reference center to provide the standards for dosimetry in clinical 
trials conducted by this group. In addition, major efforts and funds should be devoted to 
the design and development of invasive and non-invasive clinical thermometry technology. 
Since i t is extremely d i f f i c u l t to do in situ measurements at multiple sites in deep 
seated tumors, non-invasive thermometry techniques must be developed in appropriate models, 
so that only a few reference points, such as in the surface and the center of the tumor, 
when clinically feasible, should be carried out with every treatment. As the advances in 
technology evolve I t will be important to continue clinical trials to determine the 
optimal schemas for administration of heat and irradiation or drugs to achieve the 
maximum therapeutic gain. 
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TABLE 1 
HYPERTKEP.1IA ST'JDY 
PATHQLOGICAI DlA^ riSlS - RTO?^  77-10 
INITIALS 
TUMOR 
SITE HISTOLOGY 
INITIAL 
SiZE-f.l 
TREATMENT 
XRT DOSE HYPERTHERMIA 
MAXIMUM SKIN 
SUBCUTANEOUS 
REACH c:i 
I MAXIMUM 
Iu>10R 
EG3ESSI0N 
RESPONSE 
DURATION (MONTHS) 
KHR R AXILLA EPIDERMOID 11 x l l 700 X 3 NONE NONE 501 EXPIRED 
6 HKS POST 
K?1R R BREAST EPIDERMOID 22 X 23 SCO X 3 NONE NONE 501 * 
OC L UPPER 
THIGH MELANOMA 25 X 25 600 X 3 NONE NONE lOOZ 12 
CC L UPPER 
THIGH MEUNOMA 10 X 10 500 X 3 NONE NONE IOOI 12 
cc L LOWER THIGH MELANOMA 5 X 5 700 X 3 NONE IOOI 12 
EO R CHEST 
WALL DUCTAL 15 X IS 700 X 3 NONE IOOI 3 
EO R SCAPULA DUCTAL 25 X 25 303 X 3 NONE — IOOI 3 
EH L THIGH MEUNOMA 10 X 10 700 X 3 HONE MOIST DESO IOOI 15 
EH L INGUINAL 
AREA MEUNOMA 20 X 35 800 X 3 NONE MOIST DESQ IOOI 15 
EH L INGUINAL 
AREA MEUNOMA 25 X '40 800 X 3 NONE MOIST DESO IOOI 16 
oc ABDOMINAL HALL MEUNOMA 15 X 15 800 X 3 NONE NONE IOOI 6 
oc L GROIN MEUNOMA 20 X 15 SOO X 3 NONE NONE 701 6 
m?. ANT ABD 
HAa EPIDERMOID 25 X 22 500 X 3 2«0 IIHZ BLISTER AT I'URGIN so: EXPIRED 6 HEEKS 
POST TX 
oc LEFT MID THIGH MEUNOMA 50 X 50 SOC X 3 2150 MHZ BLISTER IOOI 12 
oc LEFT MID THIGH MEUNOMA 7 X 7 SOO X 3 2150 ,MHZ BLISTER 601 1 
EO R CHEST 
WALL DUCTAL 30 X 50 500 X 3 2150 MHZ MOIST DESQ AND BLISTER 2s: 3 
LEFT 
THIGH 10 X 10 SOO X 3 2150 MHZ HOIST DESQ IOOI 16 
OC 
^11 MEUNOMA 13 X iO 500 X 3 915 MHZ NONE 01 
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TABLE 2 
PHASE MI HY?E.RTHER.^UA STUDY 
(915 raZ - 12,5 - 13°C - 90 MINUTES) 
INITIALS SITE OF Tur-^aR 
_ — 
SIZECCM) 
PERCENT 
REGRESSION 
DURATION 
(.-CNTHS) 
NOR.IAL 
TISSUE 
REACTION 
HFAT AlONF 
V.S. LEFT NECK 1x3 100 13 DRY DESQ 
W.B. SCALP 7 X 3,5 100 8 DRY DESO 
HEAT AND XRT 
J.V. 100 RAD X 5 fLOOR OF MOUTH .5 X 3,5 20 2 DRY DESQ 
H.B. 100 RAD X 7 LEFT NECK 1 X 3 40 1 DRY DESQ 
CH. 100 RAD X 8 RIGHT NECK 1 X 1 100 3 DRY DESQ 
D.S. 100 RAD X 6 RIGHT NECK 2.5 X 2 100 2 DRY DESQ 
P.L. 100 RAO X 10 LEFT NECK IOO 5 DRY DESQ 
L.H. 100 RAD X 10 LEFT NECK 100 7 DRY DESQ 
ADENOCARCINOMA 
HEAT ALONE 
6.W. BREAST/CHEST WALL 18 X 15 25 i DRY DESQ 
J.K. BREAST/CHEST WALL 18 X 9 25 6 DRY DESQ 
P.S. 
HFAT ANn XRT 
BREAST/CHEST WALL 15 X U 15 2 DRY DESQ 
I.A. 100 RAD X 5 BREAST/RIGHT NECK 5 X 3 10 2 DRY DESQ 
I.A. 100 RAD X 5 BREAST/AXILU 3x2 15 2 DRY DESQ 
M.W. 100 RAD X 10 BREAST/NECK NODES 5.5 X 3 100 1 DRY DESQ 
n.w. 100 RAD X 10 BREAST/NECK NODES 5x2 100 1 DRY DESQ 
H.W. 100 RAD X 10 BREAST/NECK NODES 1 X 2,5 100 1 DRY DESQ 
J.H. 100 RAD X 10 BREAST/CHEST WALL 3 X 3 100 5 ERYTHEMA 
B.n. 100 RAO X 8 LUNG/RIGHT NECK 1 X .5 80 3 ERYTHEMA 
B.M. 100 RAD X 8 LUNG/CHEST WALL 1 X ,5 80 3 ERYTHEMA 
(ALL PATIENTS HAD PREVIOUS IRRADIATION TO SITE HOV TREATED) 
BCTASTATIC MELANOMA 
R.H. 
P.M. 
WjK. 
M.K. 
H.R. 
L.R. 
HFAT AND XRT 
100 RAO X 8 
100 RAD X 8 
100 RAD X 5 + 
500 RAD X 5 
XRT ALQNE 
HFAT tm XRT 
100 RAD X 10 
100 RAD X U 
RIGHT POST-
AURICUUR 
GROIN 
RiGtfT LEG 
RIGHT LEG 
2 X 1,5 
8x3 
5 35 1,5 
5 X 5 
iOG 
IOC 
80 
(REGROWTH) 
CTFT TISSUE SARCQ.MA 
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FIGURE lA 
Recurrent epidermoid carcinoma of the scalp treated with heat alone. Most of the 
tumor underwent complete regression but persistent nodule at the margin was treated with 
4500 rad TD in 15 fractions, three weeks with superficial x-rays (120 KV, .3 mm cu HVL). 
FIGURE IB 
Photograph seven months after treatment showing complete regression of tumor. 
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FIGURE 2A 
Pretreatment photograph of two large ulcerated metastatic nodules (4 cm in diameter) 
in the leg. The upper lesion was treated with a combination of irradiation (5000 rad in 
11 fractions) and hyperthermia. The lower lesion was treated with the same dose of 
irradiation but without heat. 
FIGURE 2B 
1 
Photograph six months after therapy, showing over 90% regression of the tumors. 
The lower lesion, treated with irradiation alone recurred shortly thereafter. 
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